NCT07097857 Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging
| NCT ID | NCT07097857 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Singapore General Hospital |
| Condition | Peripheral Arterial Disease(PAD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2024-10-02 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2024-10-02 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention
Eligibility Criteria
Inclusion Criteria: * Patients of age 21 years and above with diabetes and undergoing lower limb arterial angioplasty * Willingness to participate in the study and undergo foot physiological assessments using SFDI Exclusion Criteria: * Mentally incompetent, younger than 21 years of age, prisoners, pregnant or breastfeeding women * Patients unable to provide informed consent * Any medical condition which makes the candidate an inappropriate subject for study participation, in the investigator's judgment
Contact & Investigator
Tze Tec Chong
PRINCIPAL INVESTIGATOR
Singapore General Hospital
Frequently Asked Questions
Who can join the NCT07097857 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 99 Years, studying Peripheral Arterial Disease(PAD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07097857 currently recruiting?
Yes, NCT07097857 is actively recruiting participants. Contact the research team at charyl.yap.j.q@sgh.com.sg for enrollment information.
Where is the NCT07097857 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT07097857 clinical trial?
NCT07097857 is sponsored by Singapore General Hospital. The principal investigator is Tze Tec Chong at Singapore General Hospital. The trial plans to enroll 15 participants.